Newly launched family health initiative and expanded online catalog aim to make people healthier by implementing small, gradual changes in lifestyle to yield big results.
Treating Patients with Type 2 Diabetes with a Very Low Calorie Diet: Consider this Proven Approach
How managing weight can prevent diabetes.
MOUNT LAUREL, NJ, October 10, 2019 — For men and women, obesity may be the single most influential risk factor for developing glucose intolerance—the hallmark of developing diabetes. It is easy then, to understand why proper nutrition and weight loss are considered cornerstones of therapy in managing type 2 diabetes.
Robard Corporation, in conjunction with a highly regarded endocrinologist, developed a Diabetes Medical Protocol. The Diabetes Protocol was the first nationally available comprehensive VLCD program documented in a prospective study that offers educational materials and medical guidelines specifically for patients with type 2 diabetes. Easily adaptable to the phased method of weight loss, the Diabetes Protocol helps overweight and obese patients with type 2 diabetes lose and control their weight.
Many studies have shown maximal decreases in blood glucose within 10 to 14 days of initiating a VLCD (Very Low Calorie Diet). This rapid response can be motivating to the person with type 2 diabetes because the symptoms of elevated blood glucose levels (e.g., polyuria, polydipsia, and fatigue) may be reduced or eliminated, along with reducing or eliminating the need for medications to control blood pressure, blood glucose, and blood lipid levels. Thus, a VLCD approach to diet and weight loss may eliminate the need to start or continue oral medications or insulin.
The goal is to decrease the risk factors for diseases related to obesity, thereby increasing overall quality of life. Several studies have documented that a VLCD helps obese patients with type 2 diabetes achieve rapid weight loss, normalization of blood glucose levels, reduction in plasma lipid levels, and reduction in blood pressure. And research shows that insulin resistance is markedly improved by weight loss.
Robard’s programs contain all the elements necessary to achieve weight loss and support weight management:
- A medically-based weight control program supervised by a physician-led team of healthcare professionals.
- Clinical guidelines for medical monitoring.
- Clinical research demonstrating benefits to obese patients with type 2 diabetes.
- Nutritionally complete, very low calorie diet (VLCD) for rapid, safe weight loss. (Physician monitoring is required to minimize the potential for health risks.)
- Multidisciplinary program of behavior modification, nutrition education, physical activity and to reinforce lifestyle changes.
- Educational materials that target the needs of patients with type 2 diabetes.
You are in a unique opportunity to improve the health of your dieters, grow your business, increase your census, and adopt a new treatment strategy that does not exist anywhere else in the current marketplace. You are in a position to not only further improve the quality of life and decrease co-morbidities for your current patients, you can also stabilize your practice in the face of economic turbulence. Introducing this new solution to your practice will aid you in growing your census, grow your business, and improve treatment outcomes for patients with type 2 diabetes.
According to a new Centers for Disease Control and Prevention report out in October 2010, one in 10 U.S. adults have diabetes now. The prevalence is expected to rise sharply over the next 40 years with as many as one in three having the disease, primarily type 2 diabetes, according to the report, published in the journal Population Health Metrics.